MAPT and Alzheimer disease: According to the prevailing amyloid hypothesis, the deposition of amyloid-β (Aβ) in the brain is the determining event in AD, although evidence shows that this hypothesis alone is not sufficient to explain many aspects of AD pathogenesis [4] and is thus considered in combination with the tau-hyperphosphorylation theory of AD development.